Loading…
Hosted by i3 Health · 🇺🇸 US · EN · 75 episodes
Established thought leaders with verified media credentials.
i3 Health’s mission is to enhance the proficiency of the interprofessional healthcare team by providing evidence-based, fair-balanced CME/NCPD/CPE-approved activities that address identified professional practice gaps and unmet educational needs.
i3 Health hosts i3 Health Podcast, a science show with 75 episodes published.
Are you treating extrapulmonary neuroendocrine carcinomas based on where they start—or what they actually are? In this faculty follow-up to their i3 Health activity (Clinical Challenges in Extrapulmonary NEC: Expert Insi
What if hitting prostate cancer earlier and harder is the key to delaying disease progression and sparing patients from invasive salvage therapies? In this follow-up to his i3 Health Virtual Tumor Board, Stephen Freedlan
Chronic inflammatory demyelinating polyneuropathy (CIDP) presents significant challenges in both diagnosis and long-term disease management. As consensus definitions, emerging targeted therapies, and research into serolo
Frontline treatment selection for newly diagnosed multiple myeloma (NDMM) is more complex than ever. With quadruplet regimens and anti-CD38 antibodies redefining the landscape, how do you choose the right therapy for eac
Think PFIC is only a pediatric disease? Think again. Progressive Familial Intrahepatic Cholestasis (PFIC) was long considered a condition exclusive to children. However, breakthroughs in genomic sequencing are revealing
The treatment of esophagogastric cancer is undergoing a profound transformation. In this episode, Yelena Janjigian, MD (MSKCC), discusses how perioperative chemoimmunotherapy and precision biomarkers are redefining the s
Click here to view the full CME/NCPD/CPE/AAPA activity and hear additional insights on the HER2-mutant NSCLC treatment landscape! https://i3health.com/course-information/nsclc-advances The FDA’s recent expanded approval
Hemophilia care is evolving faster than ever. Dr. Robert Sidonio, Jr., a leading expert from Children’s Healthcare of Atlanta, joins us to discuss the latest breakthroughs in research and clinical trials. From navigating
Schizophrenia is far more than hallucinations and delusions. In this Faculty Follow-Up, Christoph U. Correll, MD—Professor of Psychiatry and Molecular Medicine at the Zucker School of Medicine at Hofstra/Northwell and Ch
Neuroendocrine tumor (NET) care is changing fast—and the pace of innovation is only accelerating. In this episode, Aman Chauhan, MD, Associate Professor of Clinical Medicine at the University of California, San Francisco
Biliary tract cancers, including cholangiocarcinoma, are among the most complex and aggressive malignancies in oncology. In this episode, we are joined by Melinda Bachini, Chief Patient Officer at the Cholangiocarcinoma
The management of ulcerative colitis (UC) has moved far beyond simple symptom control, evolving into a sophisticated era of precision medicine fueled by an ever-expanding therapeutic armamentarium. Following his popular
This Multidisciplinary Task Force explores strategies for increasing early intervention and optimizing management of psoriatic arthritis. It features perspectives from a panel of experts discussing therapies for treatmen
The ALS treatment landscape is shifting faster than ever, with emerging clinical trial data and advances in gene‑targeted therapies reshaping how healthcare professionals think about disease management and patient suppor
Schizophrenia remains a complex challenge that significantly impacts life expectancy and daily functioning. While dopamine-blocking agents have long been the standard of care, their limitations often leave patients with
The treatment landscape for melanoma continues to evolve at a rapid pace, with new clinical trial data and therapeutic modalities refining how clinicians approach both early-stage and advanced disease. Michael A. Davies,
The treatment landscape for melanoma continues to evolve at a rapid pace, with new clinical trial data and therapeutic modalities refining how clinicians approach both early-stage and advanced disease. Michael A. Davies,
Ready to close the gap in HER2-mutant NSCLC care? Join Memorial Sloan Kettering experts Helena A. Yu, MD, and Maria Arcila, MD, for a live webinar on optimizing HER2 testing and integrating the latest targeted therapies
Join Lauren M. Madigan, MD, Associate Professor of Dermatology at the University of Utah, for a sneak peek at our upcoming live webinar, Beyond the Skin: Uncovering Systemic Mastocytosis (SM) in Dermatology Practice. In
Christoph U. Correll, MD, Professor of Psychiatry and Molecular Medicine at the Zucker School of Medicine at Hofstra/Northwell and Chair of Child and Adolescent Psychiatry at Charité University in Berlin, is currently ch
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
i3 Health Podcast has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
i3 Health Podcast is hosted by i3 Health. The show is categorised under science and has published 75 episodes.
i3 Health Podcast has published 75 episodes.
i3 Health Podcast regularly covers science. It sits in the science category.
i3 Health Podcast is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
i3 Health Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of i3 Health Podcast average 21 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates i3 Health Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 6 days ago.